CHARACTERISTICS OF LEVELS OF SERUM MARKERS OF APOPTOSIS FAS-SYSTEMS IN HIV-MONO-INFECTED PERSONS, PATIENTS WITH HIV/HCV-CO-INFECTION AND CHRONIC VIRAL HEPATITIS C-Reference-Cited by-同舟云学术

CHARACTERISTICS OF LEVELS OF SERUM MARKERS OF APOPTOSIS FAS-SYSTEMS IN HIV-MONO-INFECTED PERSONS, PATIENTS WITH HIV/HCV-CO-INFECTION AND CHRONIC VIRAL HEPATITIS C

Published:2020-01-17 Issue:4 Volume:11 Page:98-102
ISSN:2077-9828
Container-title:HIV Infection and Immunosuppressive Disorders
language:
Short-container-title:VIČ-infekc. immunosupr.

Author:

Bazykina E. A.¹,Turkutyukov V. B.²,Trotsenko O. E.¹,Kotova V. O.¹,Balakhontseva L. A.¹

Affiliation:

1. Khabarovsk Research Institute of Epidemiology and Microbiology of Rospotrebnadzor

2. Pacific State Medical University

Publisher

Baltic Medical Education Center

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health,Immunology

Reference15 articles.

1. Bobkova M.R. Immunitet i VICh-infektsiya. M.: Olimpiya Press, 2006. 240 s.

2. Strasser A., Jost P.J., Nagata S. The many roles of FAS receptor signaling in the immune system. Immunity. j. immuni. 2009. Vol. 30. No. 2. R. 180–192. DOI: 10.1016/ 2009.01.001.

3. Peptide inhibitors as novel anti-HIV therapeutics: pat. US9327009B2, MPK /B2O13/AOS1641/ Tripathi R.K., Kumar B., Ramachandran R., Tripathi J.K., Bhadauria S., Ghosh J.K; zayavitel': Council of Scientific & Industrial Research; zayavl. 01.03.2013; opubl. 06.09.2013. // URL: https://patentimages.storage.googleapis.com/cc/24/1e/f1623a0076d9dd/US9327009.pdf (data dostupa 10.10.2019)

4. Garg H, Joshi A. Host and Viral Factors in HIV-Mediated Bystander Apoptosis // Viruses. 2017. Vol. 9, No. 8. doi: 10.3390/v9080237.

5. Zhavoronok S.V., Moskaleva N.V., Tumash O.L., Baryshnikov A.Yu. Perspektivy kliniko-laboratornogo ispol'zovaniya rastvorimoi formy antigena CD95 // Nauka i innovatsii. 2014. T. 3, № 133. S. 67–72.